The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study-Reference-Cited by-同舟云学术

The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study

Published:2022-01 Issue:1 Volume:48 Page:60-66
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Ploumen R.A.W.,Keymeulen K.B.M.I.,Kooreman L.F.S.,van Kuijk S.M.J.,Siesling S.,Smidt M.L.,van Nijnatten T.J.A.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference34 articles.

1. International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fifth symposium on primary systemic therapy in the management of operable breast cancer, cremona, Italy (2013);Amoroso;J Natl Cancer Inst Monogr,2015

2. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer;Kaufmann;Ann Surg Oncol,2012

3. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer;Fisher;J Clin Oncol,1998

4. Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis;Spring;Clin Cancer Res,2020

5. Pathological complete response in neoadjuvant treatment of breast cancer;Cortazar;Ann Surg Oncol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial MRI findings predictive of a pathological complete response to neoadjuvant treatments in HER2-positive breast cancers;European Journal of Radiology;2024-09

2. Association of residual ductal carcinoma in situ with breast cancer treatment outcomes after neoadjuvant chemotherapy according to hormone receptor status;Discover Oncology;2024-07-17

3. Machine learning for predicting breast-conserving surgery candidates after neoadjuvant chemotherapy based on DCE-MRI;Frontiers in Oncology;2023-08-09

4. Association of Residual Ductal Carcinoma In Situ with Breast Cancer Treatment Outcomes after Neoadjuvant Chemotherapy according to Hormone Receptor Status;2023-06-29

5. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis;European Radiology;2023-04-05